{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:07:23Z","timestamp":1746245243082,"version":"3.40.4"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Immune response to vaccination is assessed when adequate vaccine protection is in question or immunosuppression is imminent through measurement of antibody levels, which wane as time from vaccination increases. The serologic cutoff value for adequate response is based on thresholds derived from studies in adults, and age-appropriate thresholds for children have not been established. We sought to investigate age-specific differences in antibody levels in healthy children to guide determination of vaccine immunity status when clinically indicated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This cross-sectional study assessed clinical serology for measles, mumps, rubella (MMR), varicella, and hepatitis B (HepB) in an age-stratified cohort of 471 healthy children who were up to date for vaccination (1 to 18 years). Remnant specimens with sufficient volume were collected from July 23, 2019, to November 17, 2020, as convenience samples and chart reviewed for inclusion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>While children of all ages had detectable titers to MMR, median titers for HepB and varicella waned by ages 11 to 12 and 9 to 10 years, respectively. Children had titers above adult thresholds for MMR at all measured timepoints, retrospectively resulting in 24.6% (95% CI, 21.6%\u201327.8%) of children having an inappropriate MMR classification when adult instead of pediatric thresholds were used. Current use of HepB and varicella serology may be inappropriate due to the rapid waning of titers. The adequacy of an individual\u2019s response to one vaccine component did not infer adequate responses to other components.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Application of age-appropriate reference intervals for vaccine serologic tests will provide a foundation for improved treatment recommendations and standards of care.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/clinchem\/hvaf020","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T12:03:23Z","timestamp":1742385803000},"page":"577-586","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric Vaccine-Induced Antibody Thresholds: Rethinking Pre-Immunosuppression Serologic Testing and Revaccination Implications"],"prefix":"10.1093","volume":"71","author":[{"given":"Megan Culler","family":"Freeman","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, University of Pittsburgh, School of Medicine , Pittsburgh, PA ,","place":["United States"]},{"name":"Institute for Infection, Inflammation, and Immunity (i4Kids), UPMC Children\u2019s Hospital of Pittsburgh , Pittsburgh, PA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Sinder","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Pittsburgh , Pittsburgh, PA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Conway","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Pittsburgh Medical Scientist Training Program , Pittsburgh, PA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Chamseddine","sequence":"additional","affiliation":[{"name":"Division of Allergy and Immunology, Boston Children's Hospital, Harvard Medical School , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam Faiz","family":"Nassar","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, CHOP Care Network , Philadelphia, PA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley J","family":"Wheeler","sequence":"additional","affiliation":[{"name":"School of Computing and Information, University of Pittsburgh , Pittsburgh, PA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Anderson","sequence":"additional","affiliation":[{"name":"Bio-Rad Laboratories, Inc., Hercules , CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7851-9836","authenticated-orcid":false,"given":"Sarah E","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh, School of Medicine , Pittsburgh, PA ,","place":["United States"]},{"name":"Department of Pathology, University of Pittsburgh Medical Center , Pittsburgh, PA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"2025050208371408400_hvaf020-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","article-title":"Screening and testing for hepatitis B virus infection: CDC recommendations United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"MMWR Recomm Rep"},{"key":"2025050208371408400_hvaf020-B2","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: reevaluation of protective titers","volume":"162","author":"Chen","year":"1990","journal-title":"J Infect Dis"},{"key":"2025050208371408400_hvaf020-B3","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1086\/529448","article-title":"Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella","volume":"197","author":"Breuer","year":"2008","journal-title":"J Infect Dis"},{"key":"2025050208371408400_hvaf020-B4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ajcp\/106.2.170","article-title":"Rubella immunity: defining the level of protective antibody","volume":"106","author":"Skendzel","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"2025050208371408400_hvaf020-B5","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1128\/JCM.43.9.4847-4851.2005","article-title":"Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays","volume":"43","author":"Mauldin","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2025050208371408400_hvaf020-B6","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"key":"2025050208371408400_hvaf020-B7","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025050208371408400_hvaf020-B8","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00467-013-2538-0","article-title":"Seroprotection for hepatitis B in children with nephrotic syndrome","volume":"28","author":"Mantan","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"2025050208371408400_hvaf020-B9","first-page":"969","article-title":"Markedly decreased antibody titers against hepatitis B in previously immunised children presenting with juvenile idiopathic arthritis","volume":"31","author":"Maritsi","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2025050208371408400_hvaf020-B10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1399-3046.2011.01600.x","article-title":"Successful serology-based intervention to increase protection against vaccine-preventable diseases in liver-transplanted children: a 19-yr review of the Swiss national reference center","volume":"16","author":"L\u2019Huillier","year":"2012","journal-title":"Pediatr Transplant"},{"key":"2025050208371408400_hvaf020-B11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1399-3046.2006.00602.x","article-title":"Demand for evaluation of vaccination antibody titers in children considered for renal transplantation","volume":"11","author":"Prelog","year":"2007","journal-title":"Pediatr Transplant"},{"key":"2025050208371408400_hvaf020-B12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2025050208371408400_hvaf020-B13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiology"},{"key":"2025050208371408400_hvaf020-B14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2021.12.282","article-title":"Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review","volume":"162","author":"Kuenzig","year":"2022","journal-title":"Gastroenterology"},{"key":"2025050208371408400_hvaf020-B15","first-page":"619","article-title":"Prevalence of inflammatory bowel disease in pediatric and adult populations: recent estimates from large national databases in the United States, 2007\u20132016","volume":"26","author":"Ye","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2025050208371408400_hvaf020-B16"},{"key":"2025050208371408400_hvaf020-B17","doi-asserted-by":"crossref","first-page":"666114","DOI":"10.3389\/fimmu.2021.666114","article-title":"False positive results in SARS-CoV-2 serological tests for samples from patients with chronic inflammatory diseases","volume":"12","author":"Kharlamova","year":"2021","journal-title":"Front Immunol"},{"key":"2025050208371408400_hvaf020-B18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1515\/cclm-2021-1288","article-title":"Interferences in immunoassays: review and practical algorithm","volume":"60","author":"Wauthier","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2025050208371408400_hvaf020-B19","doi-asserted-by":"crossref","first-page":"910026","DOI":"10.3389\/fped.2022.910026","article-title":"Efficacy, immunogenicity and safety of vaccination in pediatric patients with autoimmune inflammatory rheumatic diseases (pedAIIRD): a systematic literature review for the 2021 update of the EULAR\/PRES recommendations","volume":"10","author":"Jansen","year":"2022","journal-title":"Frontiers Pediatrics"},{"key":"2025050208371408400_hvaf020-B20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/annrheumdis-2022-222574","article-title":"EULAR\/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021","volume":"82","author":"Jansen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025050208371408400_hvaf020-B21","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1016\/j.vaccine.2019.07.049","article-title":"Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: a 10-year follow-up","volume":"37","author":"Carryn","year":"2019","journal-title":"Vaccine"},{"key":"2025050208371408400_hvaf020-B22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.vaccine.2017.12.075","article-title":"Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine","volume":"36","author":"Seagle","year":"2018","journal-title":"Vaccine"},{"key":"2025050208371408400_hvaf020-B23","doi-asserted-by":"crossref","first-page":"19071","DOI":"10.1073\/pnas.1905570116","article-title":"Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood","volume":"116","author":"Rasheed","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025050208371408400_hvaf020-B24","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"2025050208371408400_hvaf020-B25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/jiv748","article-title":"Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose","volume":"214","author":"Bruce","year":"2016","journal-title":"J Infect Dis"},{"key":"2025050208371408400_hvaf020-B26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1128\/CVI.00694-12","article-title":"Immunity to hepatitis B virus (HBV) infection two decades after implementation of universal infant HBV vaccination: association of detectable residual antibodies and response to a single HBV challenge dose","volume":"20","author":"Spradling","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"2025050208371408400_hvaf020-B27","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.vaccine.2021.02.074","article-title":"Correlation of protection against varicella in a randomized phase III varicella-containing vaccine efficacy trial in healthy infants","volume":"39","author":"Habib","year":"2021","journal-title":"Vaccine"},{"key":"2025050208371408400_hvaf020-B28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpeds.2015.12.072","article-title":"Hospitalization for varicella and zoster in children with inflammatory bowel disease","volume":"171","author":"Adams","year":"2016","journal-title":"J Pediatrics"},{"key":"2025050208371408400_hvaf020-B29"},{"key":"2025050208371408400_hvaf020-B30","doi-asserted-by":"crossref","first-page":"e02127-19","DOI":"10.1128\/JVI.02127-19","article-title":"Persistence of varicella-zoster virus-specific plasma cells in adult human bone marrow following childhood vaccination","volume":"94","author":"Eberhardt","year":"2020","journal-title":"J Virol"},{"key":"2025050208371408400_hvaf020-B31","doi-asserted-by":"crossref","first-page":"e00136-20","DOI":"10.1128\/JCM.00136-20","article-title":"Performance characteristics of a multiplex flow immunoassay for detection of IgG-class antibodies to measles, mumps, rubella, and varicella-zoster viruses in presumptively immune health care workers","volume":"58","author":"Theel","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2025050208371408400_hvaf020-B32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.vaccine.2017.12.002","article-title":"Declining measles antibodies in the era of elimination: Australia\u2019s experience","volume":"36","author":"Gidding","year":"2018","journal-title":"Vaccine"},{"key":"2025050208371408400_hvaf020-B33","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.3928\/00904481-20150410-08","article-title":"Vaccine-preventable outbreaks: still with us after all these years","volume":"44","author":"Ruderfer","year":"2015","journal-title":"Pediatr Ann"},{"key":"2025050208371408400_hvaf020-B34","doi-asserted-by":"crossref","first-page":"e01339-23","DOI":"10.1128\/jcm.01339-23","article-title":"Diagnostic accuracy of commercially available serological tests for the detection of measles and rubella viruses: a systematic review and meta-analysis","volume":"62","author":"Zubach","year":"2024","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/71\/5\/577\/62384646\/hvaf020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/71\/5\/577\/62384646\/hvaf020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:33:40Z","timestamp":1746192820000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/71\/5\/577\/8071457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3,19]]},"published-print":{"date-parts":[[2025,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvaf020","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"type":"print","value":"0009-9147"},{"type":"electronic","value":"1530-8561"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,3,19]]}}}